<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Limited information is current available on the molecular and immunophenogenotypic characteristics of CD30-positive anaplastic large cell (ALC) <z:hpo ids='HP_0002665'>lymphomas</z:hpo> occurring in human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV)-infected individuals </plain></SENT>
<SENT sid="1" pm="."><plain>To address this issue, the authors have undertaken a combined analysis of these <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in a comparison with other Epstein-Barr virus (EBV)-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in the setting of <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty-one <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-related <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, including five CD30-positive ALC and 11 small noncleaved cell (SNCC) <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and five <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) specimens were characterized regarding the immunophenogenotypic features, the frequency and subtype distribution of EBV (as defined by in situ hybridization [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>], Southern blot, and a polymerase chain reaction [PCR] amplification of the EBV nuclear antigen-2 [EBNA-2] region) antigen expression (latent membrane protein-1 [LMP-1], EBNA-2, and for alterations of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene p53 </plain></SENT>
<SENT sid="3" pm="."><plain>Combined immunophenotypic and immunogenotypic analyses showed a derivation from anomalously matured B cells in four of five CD30-positive ALC <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, whereas SNCC showed features of mature B cells; no evidence of immunoglobulin or TCR gene rearrangement could be obtained in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> cases </plain></SENT>
<SENT sid="4" pm="."><plain>Combined <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> and Southern blot analyses revealed that EBV was more strictly associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> (five of five) and CD30-positive ALC <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (four of five) than with SNCC <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (four of 11) </plain></SENT>
<SENT sid="5" pm="."><plain>EBV-positive samples from CD30-positive ALC <z:hpo ids='HP_0002665'>lymphomas</z:hpo> carried type 1 EBV (two of two specimens tested), whereas both EBV subtypes were observed in SNCC <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> samples </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three forms of <z:mp ids='MP_0001799'>viral</z:mp> latent gene expression were found in the EBV positive CD30-positive ALC <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>SNCC specimens did not express LMP-1 or EBNA-2, whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> specimens expressed LMP-1 (four of five tested) but no EBNA-2 </plain></SENT>
<SENT sid="8" pm="."><plain>Immunostaining for ZEBRA was consistently negative </plain></SENT>
<SENT sid="9" pm="."><plain>HHV-6 DNA sequences were detected by PCR in one SNCC of the 19 specimens analyzed </plain></SENT>
<SENT sid="10" pm="."><plain>Three out of five CD30-positive ALC <z:hpo ids='HP_0002665'>lymphoma</z:hpo> specimens and six of 10 SNCC showed nuclear staining for p53 </plain></SENT>
<SENT sid="11" pm="."><plain>No mutation was detected in any of the three CD30-positive Alc <z:hpo ids='HP_0002665'>lymphoma</z:hpo> analyzed, whereas an aberrant SSCP pattern was found in <z:hpo ids='HP_0000001'>all</z:hpo> the four SNCC samples tested </plain></SENT>
<SENT sid="12" pm="."><plain>At variance with SNCC <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-related B-cell CD30- positive ALC <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are strictly associated with <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> and may also express the broad lymphoblastoid cell line-like (LMP-1-positive, EBNA-2-positive) pattern, and lack p53 genetic lesions </plain></SENT>
<SENT sid="13" pm="."><plain>Unlike EBV, HHV-6 probably does not represent a relevant factor involved in the pathogenesis of CD30-positive ALC and other HIV related <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>